Alder Biopharma (ALDR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALDR | AMGN | VRTX | REGN | BMY |
| Company | Alder Biopharma | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 18.95 | 313.39 | 401.50 | 926.94 | 43.90 |
| High | 19.12 | 322.60 | 405.67 | 958.13 | 44.33 |
| Low | 18.83 | 308.68 | 397.59 | 926.94 | 43.69 |
| Last | 18.88 | 311.29 | 401.08 | 957.00 | 43.99 |
| Change | -0.04 | +32.90 | +0.92 | +19.39 | +0.29 |
| % Change | -0.21% | +11.82% | +0.23% | +2.07% | +0.66% |
| Volume | 29,121,700 | 9,644,601 | 1,064,000 | 547,300 | 12,104,399 |
| 20-Day Average Volume | 5,270,225 | 2,646,885 | 1,022,600 | 518,580 | 14,464,405 |
| Previous Close | 18.92 | 278.39 | 400.16 | 937.61 | 43.70 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.86 | 272.27 | 398.43 | 909.87 | 47.46 |
| 20-Day Raw Stochastic | 48.94% | 81.73% | 63.17% | 98.64% | 7.87% |
| 20-Day Relative Strength | 79.65% | 72.10% | 47.14% | 59.08% | 29.25% |
| Weighted Alpha | -4.50 | +33.76 | +14.36 | +26.69 | -36.67 |
| Today's Opinion | 88% Buy | 24% Buy | 8% Buy | 72% Buy | 100% Sell |
| Previous Opinion | 88% Buy | 16% Sell | 8% Buy | 48% Buy | 88% Sell |
| Last Month's Opinion | 24% Buy | 24% Sell | 24% Buy | 56% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 10/14/19 | +15.30% since 04/26/24 | +0.91% since 04/26/24 | +8.36% since 04/26/24 | -1.92% since 04/26/24 |
| Low | 18.83 on 10/21/19 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 883.20 on 04/29/24 | 43.33 on 05/02/24 |
| High | 19.12 on 10/21/19 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 958.13 on 05/03/24 | 45.38 on 04/29/24 |
| 1-Month | |||||
| %Chg | +1.29% since 09/20/19 | +13.44% since 04/03/24 | -1.89% since 04/03/24 | +0.64% since 04/03/24 | -15.70% since 04/03/24 |
| Low | 18.60 on 09/23/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 19.12 on 10/21/19 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 962.20 on 04/04/24 | 52.08 on 04/04/24 |
| 3-Month | |||||
| %Chg | +92.26% since 07/19/19 | -3.68% since 02/02/24 | -5.56% since 02/02/24 | +1.25% since 02/02/24 | -9.69% since 02/02/24 |
| Low | 8.39 on 09/09/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.33 on 05/02/24 |
| High | 19.12 on 10/21/19 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | +48.90% since 04/18/19 | +15.35% since 11/03/23 | +6.61% since 11/03/23 | +17.15% since 11/03/23 | -16.72% since 11/03/23 |
| Low | 8.39 on 09/09/19 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.33 on 05/02/24 |
| High | 19.12 on 10/21/19 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,582,842 | 166,968,480 | 103,662,736 | 105,042,232 | 89,172,128 |
| Shares Outstanding, K | 83,837 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -296,430,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 2.64 | 0.60 | 0.39 | 0.17 | 0.45 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | 9.55 on 05/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 11/04/19 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.94 | 29.77 | 25.27 | 41.62 |